Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for postherpetic neuralgia and herpes zoster, applied in drug combinations, nervous system diseases, pharmaceutical formulations, etc., can solve the problems of unsatisfactory curative effect, restricting clinical application, and far from effectively relieving the quality of life of patients with pain , to achieve the effects of low incidence of adverse reactions, improvement of clinical symptoms, and pain relief
Inactive Publication Date: 2010-01-27
邢怀广 +2
View PDF2 Cites 1 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Western medicine generally adopts antiviral, anti-inflammatory and analgesic and glucocorticoid drugs for treatment, and some people use carbamazepine or polyfiltrate for treatment, but the curative effect is not satisfactory, and there are gastrointestinal irritation, secondary infection, neurological symptoms, etc. Systemic and other adverse reactions, hypertension, diabetes, pregnancy, breast-feeding patients and many other problems restrict its clinical application, and it is far from achieving the purpose of effectively relieving pain and improving the quality of life of patients
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
example 1
[0036] Example 1: A kind of medicine for the treatment of postherpetic neuralgia, the crude drug of making active ingredient is according to following weight: Bupleurum 10g, Polygonum cuspidatum 20g, Lonicera vine 30g, Toosendan 6g, Rhizoma 10g, Salvia miltiorrhiza 15g, fried white mustard seeds 6g, Xu Changqing 10g, Pittosporin 10g, Caulis Spatholobus 15g, Noctilucia 15g, scorpion 3g, centipede 2 (5g), licorice 6g.
[0037] Preparation and use method: Grind scorpion and centipede into fine powder respectively; one dose of other raw materials, decoct twice according to the routine, and mix the two times of liquid medicine to obtain a medicinal juice of about 300ml; the medicinal juice and the aforementioned fine powder of scorpion and centipede are as early as , Take it twice in the evening, one dose a day.
example 2
[0038] Example 2: A kind of medicine for the treatment of postherpetic neuralgia, the crude drug of active ingredient is made into following weights: Bupleurum 15g, Polygonum cuspidatum 20g, Lonicerae vine 25g, Toosendan 8g, Rhizoma 15g, Salvia miltiorrhiza 25g, fried white mustard seeds 7g, Xu Changqing 18g, Pittosporin 12g, Caulis Spatholobus 18g, Nocturna vine 18g, scorpion 4g, centipede 1 (4g), licorice 8g.
[0039] Preparation and usage method: Same as Example 1.
example 3
[0040] Example three: a kind of medicine for the treatment of postherpetic neuralgia, the crude drug that makes active ingredient is according to following weight: Bupleurum bupleuri 12g, Polygonum cuspidatum 21g, Lonicerae vine 28g, Toosendan 9g, Radix chinensis 24g, Salvia miltiorrhiza 30g, fried white mustard seed 7g, Xu Changqing 18g, Pittosporum piscifolia 12g, Caulis Spatholobus 18g, Nocturna vine 18g, scorpion 4g, centipede 1 (3g), licorice 8g.
[0041] Preparation and usage method: Same as Example 1.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a medicine for treating postherpetic neuralgia, and belongs to Chinese medicine preparation. The invention is characterized in that the raw materials for producing the effective components of the medicine have the following part by weight: bupleurum root is 10 to 15 parts, giant knotweed is 10 to 20 parts, honey-suckle stem is 15 to 30 parts, toosendan fruit is 6 to 10 parts, rhizoma corydalis is 10 to 24 parts, red sage root is 15 to 30 parts, parched Brassica alba boiss is 6 to 10 parts, root of swallowwort is 10 to 24 parts, bark of himalayan coralbean is 10 to 15 parts, lentherleaf millettia is 15 to 24 parts, fleece-flower stem is 15 to 24 parts, scorpion is 3 to 6 parts, centipede is 3 to 6 parts, and licorice root is 6 to 10 parts. The medicines are combined together to play the functions of eliminating dampness and heat, clearing away remaining poisonous influence, resolving phlegm and removing dampness, promoting flow of qi and blood circulation and activating the channels and relieving pains. The medicine can rapidly and effectively relieve the postherpetic neuralgia, improve other clinical symptoms and the adverse effects brought by the disease to the body and the spirit of a patient, with the total effectiveness ratio of up to 98.33 percent.
Description
technical field [0001] The invention relates to a traditional Chinese medicine preparation, in particular to a medicine for treating postherpetic neuralgia. Background technique [0002] Herpes zoster is a common disease caused by varicella zoster virus, a neurotropic virus that often causes severe neuralgia, and the pain becomes worse with age. Some patients, especially middle-aged and elderly patients, often leave intractable neuralgia after herpes subsides, which lasts for several months or even longer; it brings great pain to patients and affects normal work and life. Western medicine generally adopts antiviral, anti-inflammatory and analgesic and glucocorticoid drugs for treatment, and some people use carbamazepine or polyfiltrate for treatment, but the curative effect is not satisfactory, and there are gastrointestinal irritation, secondary infection, neurological symptoms, etc. Systemic and other adverse reactions and many problems such as high blood pressure, diabet...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more